The global next generation sequencing market is set to witness a growth rate of ~15% in the next 5 years. Rising demand for ...
Market Research Report Highlights Key Trends, Drivers, and InnovationsThe DNA sequencing market has emerged as a cornerstone ...
Details: Two FFPE-derived DNA samples (colon and liver) alongside a high-quality genomic DNA control (NA12878) were used to ...
The market presents significant opportunities in companion diagnostics for personalized medicine and point-of-care testing ...
Genomics remains the largest platform, while single-cell multiomics and metabolomics are set for fastest growth as pharma and biotech R&D spending accelerates worldwide.Austin, Sept. 26, 2025 (GLOBE ...
The table shows the representative samples and their associated read counts. AutoNormalization effectively normalized the ...
Embleema, in partnership with GRAVL and Aria Diagnostics (ARIA), has secured a $5 million Department of Defense ...
Thermo Fisher Scientific Inc. acts as a mission-critical supplier and service partner for the global life science industry.
The CDx System is a combination medical device consisting of the OncoGuide™ OncoScreen™ Plus CDx Kit and the OncoGuide™ ...
The Fund had a strong second quarter, outperforming its benchmarks, the Russell 1000 Growth Index and the S&P 500 Index. Read ...
Asianet Newsable on MSN
Upstart Stock Eyes Recovery After 5-Day Losing Streak — Retail Wonders If A Short Squeeze Is Due
According to Jefferies analysts, Upstart's stock short interest jumped 606 basis points to 27.7% in August, the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback